TNAP expressing adventitial pericytes contribute to myogenesis during foetal development
Vascular Pharmacology · 2025
DOI: 10.1016/j.vph.2025.107489 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vascular Pharmacology, 2025. Verfasst von I Fancello und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cell Matrix Biology & Regenerative Medicine, FBMH, University of Manchester, UK. Hauptthemen laut MEDLINE: Muscle Development, Pericytes, Muscle, Skeletal, Fetal Development. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Horizon 2020, Horizon 2020 Framework Programme, H2020 Marie Skłodowska-Curie Actions.
Abstract (Originalsprache)
OBJECTIVE: During growth and differentiation of skeletal muscle, cell types other than canonical myoblasts can be recruited to a myogenic fate. Among these, TNAP+ pericytes can differentiate into skeletal or smooth muscle cells during postnatal growth and contribute to muscle regeneration. However, their role in muscle development has not been investigated. This study aims to characterise pericyte fate choices during embryonic and foetal myogenesis, occurring in the second half of gestation. APPROACH AND RESULTS: Using Cre-loxP lineage tracing with multiple reporters including the multifluorescent Confetti, we labelled TNAP+ precursors in vivo and assessed the smooth or skeletal muscle differentiation in their lineage at a perinatal stage. We found that TNAP+ cells contribute in vivo to skeletal and smooth muscle cells, as well as other pericytes, also during pre-natal muscle development. The resulting clones showed that such fate choices are likely to depend on distinct unipotent progenitors rather than multipotent progenitors. In addition, we isolated and differentiated in vitro foetal cells derived from TNAP+ precursors, which showed that they are not spontaneously myogenic unless co-cultured with other skeletal muscle cells. CONCLUSIONS: This work extends our understanding of the differentiative potency of these non- canonical skeletal muscle progenitors during prenatal life, with a view to a future application of this knowledge to optimise cell therapies for muscle wasting disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cell Matrix Biology & Regenerative Medicine, FBMH, University of Manchester, UK.
- Division of Cell Matrix Biology & Regenerative Medicine, FBMH, University of Manchester, UK; Institute of Experimental Neurology, Division of Neurosciences, Ospedale San Raffaele, Milan, Italy; Experimental and Clinical…
Förderung
- Horizon 2020
- Horizon 2020 Framework Programme
- H2020 Marie Skłodowska-Curie Actions
Zitieren
APA
Fancello, I., Willett, S., Castiglioni, C., Amer, S., Santoleri, S., Bragg, L., Galli, F., & Cossu, G. (2025). TNAP expressing adventitial pericytes contribute to myogenesis during foetal development. Vascular Pharmacology. https://doi.org/10.1016/j.vph.2025.107489
Vancouver
Fancello I, Willett S, Castiglioni C, Amer S, Santoleri S, Bragg L, et al. TNAP expressing adventitial pericytes contribute to myogenesis during foetal development. Vascular Pharmacology. 2025. doi:10.1016/j.vph.2025.107489
BibTeX
@article{Fancello2025,
author = {Fancello, I and Willett, S and Castiglioni, C and Amer, S and Santoleri, S and Bragg, L and Galli, F and Cossu, G},
title = {TNAP expressing adventitial pericytes contribute to myogenesis during foetal development},
journal = {Vascular Pharmacology},
year = {2025},
doi = {10.1016/j.vph.2025.107489}
}
EUVIMED